Chemify key facts
as of Oct 2026- Developer of a chemical digitization platform intended to run chemical code for drug and materials discovery and chemical synthesis.
- Chemify is valued at approximately $145.1M as of Oct 2026 (last reported valuation).
- It has raised $124.2M; the latest was Grant ($3.2M) in Dec 2025.
- Notable investors include Innovate UK, Insight Partners (New York), Founders Fund, 8VC, DCVC — 27 tracked in total.
- Status: Privately Held (backing).
Chemify's last reported valuation, Oct 2025. Nothing priced has surfaced since.
- ·The complete investor list: 27 names
- ·Watch Chemify: the Monday email on marks, rounds and moves
Chemify funding rounds
No funding rounds for Chemify are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Chemify
27+Membership and data by Private Market View
Chemify valuation
Chemify's last reported valuation was $145 million in Oct 2025. No priced round, secondary trade or fund mark has surfaced since.
Chemify investors
27 investors are on record for Chemify, including Innovate UK, Insight Partners (New York), Founders Fund and 8VC. By type, the record holds 9 venture capital firms and 3 family offices.
About Chemify
Developer of a chemical digitization platform intended to run chemical code for drug and materials discovery and chemical synthesis. The company's software involves a chemical programming language, natural language recognition for the translation of synthetic procedures, and a comprehensive ontology that allows for the straightforward creation of processes with insight into reaction conditions and flagging potential problems, enabling scientists to have detailed real-time reaction telemetry.
- Sector
- Healthcare
- HQ
- Glasgow, United Kingdom
- Founded
- 2019
- Employees
- 154
- Website
- chemify.io/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.